[1]牛 敏,杨西超,闫美茜,等.强直性脊柱炎患者肥胖与炎性指标、疾病严重程度指标和心血管疾患危险因素指标相关性分析[J].陕西医学杂志,2021,50(11):1383-1386.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.015]
　NIU Min,YANG Xichao,YAN Meixi,et al.Correlation between obesity and inflammatory indicators,disease severity indicators and cardiovascular disease risk factors in patients with ankylosing spondylitis[J].,2021,50(11):1383-1386.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.015]
点击复制

强直性脊柱炎患者肥胖与炎性指标、疾病严重程度指标和心血管疾患危险因素指标相关性分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年11期
页码:
1383-1386
栏目:
临床研究
出版日期:
2021-11-05

文章信息/Info

Title:
Correlation between obesity and inflammatory indicators,disease severity indicators and cardiovascular disease risk factors in patients with ankylosing spondylitis
作者:
牛 敏1; 杨西超1; 闫美茜1; 张吉涛1; 李 英2
(1.西安市红会医院,陕西 西安 710054; 2.西安国际医学中心医院,陕西 西安710100)
Author(s):
NIU Min; YANG Xichao; YAN Meixi; ZHANG Jitao; LI Ying
(Xi'an Honghui Hospital,Xi'an 710054,China)
关键词:
强直性脊柱炎;  肥胖;  炎症;  疾病严重程度;  心血管因素;  相关性
Keywords:
Ankylosing spondylitis;  Obesity;  Inflammation;  Disease severity;  Cardiovascular factors;  Correlation
分类号:
R 593.23
DOI:
DOI:10.3969/j.issn.1000-7377.2021.11.015
文献标志码:
A
摘要:
目的:探讨强直性脊柱炎患者肥胖与炎性指标、疾病严重程度指标和心血管疾患危险因素指标之间的相关性。方法:强直性脊柱炎患者125例,根据体重指数(BMI)分为BMI 1组(体重过低,BMI<18.5 kg/m2)共36例,BMI 2组(体重正常,BMI 18.5～23.9 kg/m2)共63例,BMI 3组(超重,BMI≥24 kg/m2)共26例; 比较不同BMI组强直性脊柱炎患者炎性因子(血沉、CRP、TNF-α、IL-2)、病情相关指标[晨僵时间、枕墙距、指地距、强直性脊柱炎疾病活动指数(BASDAI)、强直性脊柱炎疾病功能指数(BASFI)、胸廓扩张度、腰椎活动度等]及心血管疾患危险因素指标(包括收缩压和舒张压、空腹血糖、总胆固醇、甘油三酯)等差异,采用Pearson法分析BMI与炎症、疾病严重程度和心血管疾患危险因素指标的相关性。结果:BMI 1组、BMI 2组 和BMI 3组 患者间的心血管疾患危险因素指标、炎性因子、晨僵时间、枕墙距、指地距有逐渐增高趋势(均P<0.01),而血沉、BASFI、BASDAI、胸廓扩张度、腰椎活动度有逐渐下降趋势(均P<0.01)。BMI与强直性脊柱炎患者的胸廓扩张度、腰椎活动度(Schober试验)呈负直线相关(r=-0.608、-0.617,均P<0.05),与晨僵持续时间呈正直线相关(r=0.712,P<0.05)。结论:不同BMI水平强直性脊柱炎患者在心血管疾患危险因素相关指标、炎性反应指标、疾病严重程度指标上存在一定的差异,仅肥胖与强直性脊柱炎病情严重程度存在内在联系,故减肥可能为降低疾病活动性和改善患者功能的一个有效途径。
Abstract:
Objective:To investigate the relationship between obesity and inflammatory indicators,disease severity indicators and cardiovascular disease risk factors in patients with ankylosing spondylitis.Methods:125 patients with ankylosing spondylitis were divided into BMI 1 group(underweight,BMI<18.5 kg/m2,36 cases),BMI 2 group(normal weight,BMI 18.5～23.9 kg/m2,63 cases),and BMI 3 group(overweight,BMI≥24 kg/m2,26 cases)according to BMI.The inflammatory factors(ESR,CRP,TNF-α,IL-2),disease-related indicators(morning stiffness,occipital wall distance,finger ground distance,BASDAI,BASFI,thoracic expansion,lumbar spine mobility)and cardiovascular disease risk factors(systolic and diastolic blood pressure,fasting blood glucose,total cholesterol,triglycerides)were compared among three groups.Pearson method was used to analyze the correlation between BMI and inflammatory indicators,disease severity indicators and cardiovascular disease risk factors.Results:The cardiovascular disease risk factors,inflammatory factors,morning stiffness,occipital wall distance,and finger ground distance among patients in BMI 1,BMI 2 and BMI 3 groups gradually increased(all P<0.01),while ESR,BASFI,BASDAI,thoracic expansion and lumbar spine mobility showed a gradual decrease(all P<0.01).BMI had a negative linear correlation with the thoracic expansion and lumbar spine mobility(Schober test)in patients with ankylosing spondylitis(r=-0.608,-0.617,both P<0.05),and a positive linear correlation with the duration of morning stiffness(r=0.712,P<0.05).Conclusion:Ankylosing spondylitis patients with different BMI levels have certain differences in cardiovascular risk factors related indicators,inflammatory indicators,and disease severity indicators.Only obesity is intrinsically related to the severity of ankylosing spondylitis,so weight loss is an possible effective way to reduce disease activity and improve patient function.

参考文献/References:

[1] Dafne C,Emilce E,Schneeberger GC.SASDAS:A practical tool to measure disease activity in axspa patients.Comments on “a prospective study of novel disease activity indices for ankylosing spondylitis”[J].Rheumatology International,2021,41(11):839-840.
[2] 陈国阳,苏松森,张清平,等.脂肪因子、白细胞介素-6和肿瘤坏死因子-α水平与强直性脊柱炎患者骨密度相关性研究[J].中国骨质疏松杂志,2020,26(3):398-402.
[3] 中华医学会风湿病学分会.强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(8):557-559.
[4] 陈春明,国际生命科学学会中国办事处中国肥胖问题工作组联合数据汇总分析协作组.中国成人体质指数分类的推荐意见简介[J].中华预防医学杂志,2001,35(5):349-350.
[5] 宋飞鹏,胥 毅,王 越,等.CT能谱成像在早期强直性脊柱炎骶髂关节骨髓水肿及活动性诊断中价值[J].中华实用诊断与治疗杂志,2020,34(11):1157-1160.
[6] 赵 丽.强直性脊柱炎与纤维肌痛综合征的鉴别与特点分析[J].中国冶金工业医学杂志,2020,37(6):706.
[7] 郝晓娟,杜娟丽,张 强,等.以急性葡萄膜炎为首发症状的强直性脊柱炎43例临床分析[J].陕西医学杂志,2017,46(1):77-78.
[8] 王蔼平,张俊莉,刘 茜,等.强直性脊柱炎髋关节病变的相关因素分析[J].陕西中医,2012,33(6):697-699.
[9] 陈 达,姚海红.2019年美国风湿病学会美国脊柱炎协会脊柱关节炎研究治疗网络对强直性脊柱炎和放射学阴性的中轴型脊柱关节炎的治疗推荐意见更新[J].中华风湿病学杂志,2020,24(5):357-360.
[10] 陈付彩.强直性脊柱炎病因学的研究进展[J].临床医药文献电子杂志,2017,4(55):10887.
[11] 王欣荣,徐胜前,龚 勋,等.强直性脊柱炎患者X线脊柱结构损伤的影响因素分析[J].中华风湿病学杂志,2019,13(11):735-741.
[12] 李 敏,阿呷使扎,吴晓惠,等.基于DAVID脊柱生物力学测训系统对强直性脊柱炎核心肌群评估研究[J].中华风湿病学杂志,2019,10(23):656-661.
[13] 章良忠.老年强直性脊柱炎患者血清IL-18和IL-37水平及其与疗效和疾病活动度的关系[J].中国老年学杂志,2020,40(24):5245-5247.
[14] Sengupta R,Stone MA.The assessment of ankylosing spondylitis in clinical practice[J].Nat Clin Pract Rheumatol,2007,13(23):496-503.
[15] 况 凡.强直性脊椎炎患者HLA-B27与血清补体C3、C4及超敏C反应蛋白水平分析[J].陕西医学杂志,2018,47(12):1655-1656.
[16] 黄闰月.“强直”控制还应关注4件事[J].江苏卫生保健,2020(8):10-11.
[17] 张 璐,刘 云,马东红,等.中西医结合治疗强直性脊柱炎临床疗效[J].陕西中医,2017,38(4):475-477.
[18] 郭金明,张国权,阿里木江.体质指数和腰臀比对中老年妇女腰椎前凸和骶骨倾斜度的影响[J].中国骨伤,2008,21(1):30-31.
[19] 卢兆安,王传文,吕晓龙,等.强直性脊柱炎患者骨密度异常的危险因素分析[J].中国脊柱脊髓杂志,2020,30(6):546-551.
[20] 钟驾云.中青年强直性脊柱炎患者骨密度相关影响因素分析[D].上海:海军军医大学,2019.
[21] 盛长健,孙中玉,刘 健.强直性脊柱炎患者体重指数变化及相关性分析[J].中医药临床杂志,2009,21(6):520-521.

相似文献/References:

[1]戴 璐.柳氮磺胺吡啶联合益赛普治疗不同年龄强直性脊柱炎 临床效果及对患者生活质量的影响研究*[J].陕西医学杂志,2019,(2):262.
　DAI Lu..Clinical effect of sulfasalazine combined with Yisaipu on ankylosing spondylitis in different age groups and its impact on patients’ quality of life[J].,2019,(11):262.
[2]沈 健,张雨涵,曹芳蕾,等.强直性脊柱炎患者血清RANKL、TGF-β1和TGF-β2的表达及临床意义[J].陕西医学杂志,2019,(8):981.
　SHEN Jian,ZHANG Yuhan,CAO Fanglei,et al.Clinical significance of RANKL, TGF-β1 and TGF-β2 in ankylosing spondylitis[J].,2019,(11):981.
[3]沈斯瑶,刘 艳△,徐鹏刚.白芍总苷联合沙利度胺治疗强直性脊柱炎疗效及对患者活动指标、血清炎性因子水平的影响*[J].陕西医学杂志,2020,49(1):20.
　SHEN Siyao,LIU Yan,XU Penggang..Effect of total glucosides of paeony combined with thalidomide on activity indicators and serum inflammatory factors in the treatment of ankylosing spondylitis patients[J].,2020,49(11):20.
[4]屈文涛,马 静,康亚宁△,等.二维斑点追踪技术评价不同体质量指数2型糖尿病患者左心房功能[J].陕西医学杂志,2020,49(9):1138.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.021]
　QU Wentao,MA Jing,KANG Yaning,et al.Evaluation of left atrial function in type 2 diabetes patients with different body mass index by two-dimensional speckle tracking technique[J].,2020,49(11):1138.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.021]
[5]周利萍,冯前翰.儿童阻塞性睡眠呼吸暂停综合征相关危险因素研究[J].陕西医学杂志,2021,50(2):205.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.020]
　ZHOU Liping,FENG Qianhan.Risk factors of obstructive sleep apnea syndrome in children[J].,2021,50(11):205.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.020]
[6]钟社兰,陈 星.多囊卵巢综合征与失眠症共病患者临床特征及相关因素分析[J].陕西医学杂志,2023,52(4):437.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.016]
　ZHONG Shelan,CHEN Xing.Clinical characteristics and related factors of insomnia in patients with polycystic ovary syndrome[J].,2023,52(11):437.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.016]
[7]孔维娜,李 佳,赵淑华,等.代谢综合征在子宫内膜癌及其肿瘤微环境中的研究进展[J].陕西医学杂志,2023,52(11):1607.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.034]
　KONG Weina,LI Jia,ZHAO Shuhua,et al.Progress of metabolic syndrome in endometrial cancer and its tumor microenvironment[J].,2023,52(11):1607.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.034]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2021SF-074)
更新日期/Last Update: 2021-11-05